Health & Life Sciences

As global health services and markets are changing and being shaped by rapid development of healthcare technologies – resulting in more personalised treatments and the need to respond to the health and social care implications of an ageing population – the North East offers a unique environment for innovation in health and life sciences and medicines manufacturing.

With an internationally recognised innovation ecosystem and translational environment, the North East has the skills, physical assets, capabilities and networks can support the delivery of the UK’s response to this challenge through the ongoing development of our key capabilities and their strategic co-ordination.

The region’s strengths include excellence in the quality of care and a focus on health innovation and partnership between the health system, science and business.

Health and Life Sciences Steering Group 

Michael Whitaker (Chair) – Pharma North East and Innovation Board member 

Tim Hammond – Durham University 

Geraint Lewis  – Newcastle University 

Tony Alabaster – University of Sunderland 

Carolyn Horrocks  – Northumbria University 

Richard Baker – North East LEP 

Alan Welby – North East LEP 

Geoff Davison  – BioNow 

Nicola Wesley  – AHSN  

Philip Aldridge – NEPIC 

Arun Harish – CPI 

Rachel Burdis  – Invest North East England  

Sarah Pavlou – RTC North 

Dale Athey – NPL 

Kevin Cook – Sterling Pharmaceuticals 

Will Dracup – Biosignatures 

Roger Kilburn – Arcinova  

Andrew Tasker – Femeda 

Ben Cantwell – Kromek 

Andrea Burroughs – Newcastle Upon Tyne Hospitals Trust 

Peter Rippingale – North East Combined Authority 

Vicky Cuthbertson – North of Tyne Combined Authority